Pabel B.V.
PrivateLast Round
Accelerator
Oct 21, 2025
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Pabel B.V. is a biotechnology and artificial intelligence company that develops an AI-native platform for analyzing and processing neurophysiological data to accelerate CNS drug development.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Drug Discovery, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pabel B.V. Comparables
Compare Pabel B.V. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Beacon Biosignals | 77% | |
| Cumulus Neuroscience | 75% | |
| NeuraLight | 66% | |
Pabel B.V. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Oct 21, 2025 |
Pabel B.V. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nvidia Inception | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 21, 2025
Received funding from Google for Startups and Nvidia Inception.
Pabel B.V. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pabel B.V.'s valuation, stock price, and market status.